Tirzepatide is a 39-amino-acid dual GIP/GLP-1 receptor agonist
without imaging guidance 62325 with imaging guidance (ie, fluoroscopy or CT) 62326 Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal)
Fatigue can have many causes, including stress, poor sleep, hormone issues, nutritional deficiencies, or other medical concerns
Research demonstrates BPC-157's effectiveness for tendon healing in multiple studies
Patients may be asked about: Medical history Current medications Symptoms Previous vitamin B12 treatment Existing health conditions The injection itself is typically administered by a trained healthcare professional in a clinical setting
Its important to mix thoroughly after adding the water to ensure the drug goes completely into solution